Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma

Clinical Chemistry

Volumn 44, Issue 12, 1998, Pages 2490-2498

  Leary, Elizabeth Teng ^a   Wang, Tao ^b   Baker, Daniel J ^a   Cilla, Donald D ^b   Zhong, Jianhua ^b   Warnick, G Russell ^a   Nakajima, Katsuyuki ^b   Havel, Richard J ^c  

^a Pacific Biometrics Inc   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; ASCORBIC ACID; BILIRUBIN; CHOLESTEROL; CHYLOMICRON; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANALYZER; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; ULTRACENTRIFUGATION;

EID: 0031700511     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bainton D, Miller NE, Bolton CH, Yamell JWG, Sweetnam PM, Baker IA, et al. Plasma triglyceride and high density lipoproteins cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992;68:60-6.
2. Salonen JT, Puska P. Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population. Int J Epidemiol 1983; 12:26-31.
3. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetière P, Claude R. Is the level of serum triglyceride a significant predictor of coronary death in 'normocholesterolemic' subjects? The Paris Prospective Study. Am J Epidemiol 1986;124:624-32.
4. Criqui MH, Heiss G, Conn R, Cowan LD, Suchindran CM, Bangdiwala S, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328:1220-5.
5. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglyceride to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992;70: 727-33.
6. Menotti A, Spagnolo A, Scanga M, Dima F. Multivariate prediction of coronary disease deaths in a 10 years follow-up of an Italian occupational male cohort. Acta Cardiol 1992;47:311-20.
7. Wilson PWF, Larson G, Castelli W. Triglycerides, HDL-cholesterol and coronary artery disease: a Framingham update on the interactions. Can J Cardiol 1994;10:5B-9B.
8. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
9. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985;71:881-8.
10. Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987;75:124-30.
11. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-70.
12. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;83-7.
13. Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscl Thromb Vase Biol 1997;17:715-22.
14. Havel RJ. Triglyceride-rich lipoprotein remnants. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of lipoprotein testing. Washington, DC: AACC Press, 1997:451-64.
15. Kameda K, Matsuzawa Y, Kubo M, Ishikawa K, Maejima I, Yamamura T, et al. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis 1984;51:241-9.
16. Pagnan A, Havel RJ, Kane JP, Kotite L. Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res 1977;18:613-22.
17. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel. Clin Chim Acta 1993;53-71.
18. Nakajima K, Okazaki M, Tanaka A, Pullinger CR, Wang T, Nakano T, et al. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I. J Clin Ligand Assay 1996;19:177-83.
19. Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 1992;33:369-80.
20. McNamara JR, Shah PK, Nelson SM, Nakajima K, Wilson PWF, Schaefer EJ. Lipoprotein remnant cholesterol and triglyceride values in coronary cases and Framingham controls [Abstract]. Circulation 1996;94:1-94.
21. Devaraj S, Vega GL, Lange R, Grundy SM, Jialal I. Remnant-like particles cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med 1998;104:445-50.
22. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, et al. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J Atheroscl Thromb 1994;1:30-6.
23. Shimizu H, Mori M, Saito T. An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria. Clin Chim Acta 1993;221:191-6.
24. Sekihara T, Nakano T, Nakajima K. High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis. Jpn J Nephrol 1996;38:220-8.
25. Oda H, Yorioka N, Okushin S, Nishida Y, Kushihata S, Ito T, et al. Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis. Nephron 1997;76:7-14.
26. Baadenjuijsen H, Demacker PNM, Hessels M, Hessels M, Boerma GJM, Penders TJ, et al. Testing the accuracy of total cholesterol assays in an external quality-control program. Effects of adding sucrose to lyophilized control sera compared with use of fresh or frozen sera. Clin Chem 1995;41:724-30.
27. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Investig 1955;34:1345-53.
28. Muñiz N. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. Clin Chem 1977;23:1826-33.
29. Poapst M, Reardon M, Steiner O. Relative contribution of triglyceride-rich lipoprotein particle size and number to plasma triglyceride concentration. Arteriosclerosis 1985;5:381-90.
30. Marcoux C, Tremblay M, Jacques H, Krimbou L, Fredenrich A, Nakajima K, et al. Plasma remnant-like particles (RLP) lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis 1998;139:161-71.
31. Krauss RM, Lingren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, et al. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 1987;2:62-6.
32. Hennig B, Chung BH, Watkins B, Alvarado A. Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins. Atherosclerosis 1992;95:235-47.
33. Gianturco SH, Bradley WA, Gotto AM Jr, Morrisett JD, Peavy DL. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Investig 1982;70:168-78.
34. Gianturco SH, Lin AH-Y, Hwang S-LC, Young J, Brown SA, Via DP, et al. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins. J Clin Investig 1988;82:1633-43.
35. Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscl Thromb 1994; 14:622-35.
36. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, et al. Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscl Thromb 1994;14:1767-74.
37. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsumura T, Ohta Y, et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis 1998;137:341-9.
38. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 1998;97:2519-26.
39. Inoue T, Riichiro M, Zasuhiro H, Isao Y, Shigenori M. Serum level of remnant like particles-cholesterol affects the endothelium-dependent coronary vascular response in human [Abstract]. Circulation 1997;96:1-393.
40. Knöfler R, Nakano T, Nakajima K, Takada Y, Takada A. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res 1995;78:161-71.
41. Saniabadi AR, Umemura K, Shimoyama M, Adachi M, Nakano M, Nakashima M. Aggregation of human blood platelets by remnant-like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb Heamost 1997;77:996-1001.
42. Tomono S, Kawazu S, Kato N, Ono T, Ishii C, Ito Y, et al. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscl Thromb 1994;1:98-102.
43. Shige H, Ishikawa T, Ikewaki K, Nishiwaki M, Higashi K, Nakajima K, et al. Remnant-like very-low-density lipoprotein isolated from hypertriglyceridemic patients by immunoaffinity chromatography suppressed 3-hydroxy-3-methylglutaryl coenzyme A activity of cultured human skin fibroblasts. Clin Chim Acta 1997;258:145-58.
44. Cilla DD, Wang T, Forbes WP, Nakajima K. Characteristics of dyslipidemia in intermittent claudication patients [Abstract]. Atherosclerosis 1997;134:344.
45. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153-8.
46. Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994:5:102-9.
47. Ikewaki K, Shige H, Nakajima K, Nakamura H. Postprandial remnant-like particles and coronary artery disease. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis X. Amsterdam: Elsevier Science B.V., 1995:200-2.
48. Akuzawa K, Nakano T, Sekiguchi I, Shimoyama M, Adachi M, Tange S, et al. Remnant-like particles-cholesterol (RLP-C) assay and its clinical application to lipid tests in a postprandial as well as fasting state. Jpn J Clin Pathol 1995;43:1159-67.